Search research articles
Contact Us
Filters
Showing results (1-10 of 177) with videos related to
Page
of 18
Sort By:
Expert Review of Anticancer Therapy
|
September 27, 2023
Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future
Fumitaka Koga
Expert Review of Anticancer Therapy
|
March 9, 2017
Impact of sarcopenia in the management of urological cancer patients
Hiroshi Fukushima, Fumitaka Koga
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 14, 2012
Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review
Fumitaka Koga, Kazunori Kihara
Translational Andrology and Urology
|
November 17, 2022
Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
Hiroshi Fukushima, Fumitaka Koga
International Journal of Molecular Sciences
|
January 6, 2016
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives
Tomokazu Ohishi, Fumitaka Koga, Toshiro Migita
Anticancer Research
|
May 6, 2009
Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90
Fumitaka Koga, Kazunori Kihara, Len Neckers
Expert Review of Anticancer Therapy
|
October 31, 2013
Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments
Fumitaka Koga, Minato Yokoyama, Hiroshi Fukushima
International Journal of Molecular Sciences
|
February 14, 2019
Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
Hiroshi Fukushima, Yasuhisa Fujii, Fumitaka Koga
International Journal of Molecular Sciences
|
September 19, 2018
Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
Fumitaka Koga, Kosuke Takemura, Hiroshi Fukushima
Antioxidants (Basel, Switzerland)
|
April 30, 2021
A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer
Kosuke Takemura, Philip G Board, Fumitaka Koga
Page
of 18
Search research articles
Search
Showing results (1-10 of 177) with videos related to
Sort By:
Page
of 18
Expert Review of Anticancer Therapy
|
September 27, 2023
Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future
Fumitaka Koga
Expert Review of Anticancer Therapy
|
March 9, 2017
Impact of sarcopenia in the management of urological cancer patients
Hiroshi Fukushima, Fumitaka Koga
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 14, 2012
Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review
Fumitaka Koga, Kazunori Kihara
Translational Andrology and Urology
|
November 17, 2022
Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
Hiroshi Fukushima, Fumitaka Koga
International Journal of Molecular Sciences
|
January 6, 2016
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives
Tomokazu Ohishi, Fumitaka Koga, Toshiro Migita
Anticancer Research
|
May 6, 2009
Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90
Fumitaka Koga, Kazunori Kihara, Len Neckers
Expert Review of Anticancer Therapy
|
October 31, 2013
Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments
Fumitaka Koga, Minato Yokoyama, Hiroshi Fukushima
International Journal of Molecular Sciences
|
February 14, 2019
Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
Hiroshi Fukushima, Yasuhisa Fujii, Fumitaka Koga
International Journal of Molecular Sciences
|
September 19, 2018
Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
Fumitaka Koga, Kosuke Takemura, Hiroshi Fukushima
Antioxidants (Basel, Switzerland)
|
April 30, 2021
A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer
Kosuke Takemura, Philip G Board, Fumitaka Koga
Page
of 18